pocketful logo light
pocketful logo light
Panacea Biotec Ltd logo

Panacea Biotec Ltd

NSE: PANACEABIO BSE: 531349

₹397.65

(2.32%)

Tue, 15 Sept 2026, 08:38 am

mtf coin illustrationMTF 5x

Panacea Biotec Share Price Live Chart

1 Day

(2.32%)

No Result Found

Summary

  • Market Cap (in Cr)

    2525.98

  • Net Profit (in Cr)

    -8.72

  • P/B

    3.32

  • Sector P/E

    33.76

  • P/E

    0

  • EV/EBITDA

    84.80

  • Debt/Equity (Industry)

    0.29

  • Interest Cover (Industry)

    4.50

  • ROCE (Industry)

    9.39

  • RONW (Industry)

    7.26

  • ROE

    -5.13

  • ROCE

    -4.31

  • Debt/Equity

    0.02

  • EPS (TTM)

    0

  • Dividend Yield

    0

  • Book Value

    134.92

  • Interest Cover

    -10.08

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters72.4872.4872.4872.4872.48
FII1.601.361.060.781.16
DII1.971.851.811.521.49
Public23.9624.3024.6625.2224.86
Government00000

Read More

Technical Analysis

RSI

38.72

MACD

-11.92

50 DMA

436.28

200 DMA

401.05

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic522.05463.20425.15404.35366.30345.50286.65
Fibonacci463.20440.72426.83404.35381.87367.98345.50
Camarilla403.28397.89392.49404.35381.71376.31370.92

Pivots Level: Classic

R3

+117.70

522.05

R2

+58.85

463.20

R1

+20.80

425.15

404.35
404.35
Pivot Point
LTP: 380.20

S1

-38.05

366.30

S2

-58.85

345.50

S3

-117.70

286.65

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    389.53

  • 20-EMA

    396.54

  • 30-EMA

    406.41

  • 50-EMA

    421.24

  • 100-EMA

    427.45

  • 200-EMA

    418.12

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
30 May 2026board-meetingsAccounts, Quarterly Results, Dividend
29 May 2026board-meetingsAccounts, Dividend
11 Feb 2026board-meetingsQuarterly Results
14 Nov 2025board-meetingsQuarterly Results
15 Sept 2025agm
17 Sept 2024agm
19 Aug 2024agmAnnual General Meeting20 Sept 2024
21 Aug 2023agmAnnual General Meeting22 Sept 2023
14 Aug 2023agm
19 Aug 2022agmAnnual General Meeting21 Sept 2022

Read More

Peer Comparison

Panacea Biotec Ltd logo

Panacea Biotec Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Panacea Biotec Ltd About

Panacea Biotec is one of India’s leading research-based biotechnology companies engaged in the business of research, development, manufacture and marketing of vaccines in India and international markets.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1984

Headquarters

CEO

Rajesh Jain

Employees

Contact

Website icon

Website

http://www.panaceabiotec.com

Email icon

Email

corporate@panaceabiotec.com; investorgrievances@pa

Phone icon

Phone

91-1762-505900

Location icon

Location

Ambala-Chandigarh Highway, , Lalru, Punjab, 140501

Read More

Panacea Biotec Ltd Company History

YearHistory
2019
  • Panacea Biotec launched ViLACT for treatment of uncontrolled Type 2 Diabetes Mellitus patients
  • Panacea Biotec received a USD 24.32 Million Award of Pentavalent Vaccine from U.N. Agencies
2021
  • RDIF and Panacea Biotec launched the production of Sputnik V in India
  • Panacea Biotec supplied the first shipment of the second component of Sputnik V vaccine produced in India
2022
  • Panacea Biotec received UNICEF and PAHO awards for supply of Pentavalent Vaccine
  • CEPI, THSTI and Panacea Biotec partnered to develop broadly protective Betacoronavirus vaccines
2023
  • Panacea Biotec launched EasyFourPol in India
  • Panacea Biotec received registration of Valganciclovir Powder for Oral Solution in Germany
  • Panacea Biotec launched Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound), a generic version of Abraxane
  • Panacea Biotec's wholly owned subsidiary launched a new range of high-quality pediatric food and nutritional products in India
2024
  • The Company received a Letter of Award from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth US$ 14.95 million.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
JUNOMONETA FINSOL PRIVATE LIMITEDbulkSell406499409.8309 Jan 2026
JUNOMONETA FINSOL PRIVATE LIMITEDbulkBuy406451409.6509 Jan 2026
IRAGE BROKING SERVICES LLPbulkSell234602423.6808 Jan 2026
IRAGE BROKING SERVICES LLPbulkBuy306922423.5808 Jan 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy438702420.4808 Jan 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell438702420.6908 Jan 2026
JUNOMONETA FINSOL PRIVATE LIMITEDbulkBuy451054419.3508 Jan 2026
QICAP MARKETS LLPbulkBuy444600423.6108 Jan 2026
HRTI PRIVATE LIMITEDbulkBuy494234417.4708 Jan 2026
QICAP MARKETS LLPbulkSell444600423.8608 Jan 2026

Read More

Panacea Biotec Ltd News

Panacea Biotec Subsidiary Faces ₹4.06 Cr GST Notice

Panacea Biotec Pharma Limited received a show cause notice for alleged excess ITC claims in FY23. The GST authority demands ₹4.06 crore including tax, interest, and penalty.

24 Jul 2026

companies

Panacea Biotec Appeals Fourth Industrial Tribunal Award

Panacea Biotec has filed an appeal against the fourth award from an Industrial Tribunal. The Hon'ble High Court has passed an interim order to prevent coercive action.

16 Jul 2026

companies

Rajesh Jain HUF acquires Panacea Biotec shares

Rajesh Jain HUF acquired 2,00,000 shares via gift from Dr. Rajesh Jain. An exemption application was filed with SEBI on July 8, 2026.

13 Jul 2026

companies

Panacea Biotec appeals tribunal awards

Panacea Biotec filed appeals against three Industrial Tribunal awards. The company disputes orders regarding workmen reinstatement and back wages.

07 Jul 2026

companies

Panacea Biotec advances DengiAll vaccine in Africa

Panacea Biotec launched the DENSTAR project to advance licensure of its DengiAll vaccine in sub-Saharan Africa. The four-year initiative is funded by the European Union.

08 Jun 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Panacea Biotec Ltd?

    As of 15/09/2026 at 2:08 PM, Panacea Biotec Ltd shares are trading at ₹397.65.

  • 2.What is the market cap. of Panacea Biotec Ltd?

    As of 15/09/2026, the market capitalization of Panacea Biotec Ltd is ₹2,438.09 crore.

  • 3.When was Panacea Biotec Ltd founded?

    Panacea Biotec Ltd was founded in 1984.

  • 4.How can I buy shares of Panacea Biotec Ltd?

    You can buy shares of Panacea Biotec Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 5.What is the shareholding pattern of Panacea Biotec Ltd?

    As of March,2026, promoters hold 72.48% in Panacea Biotec Ltd, while FIIs, DIIs and public shareholders hold 1.60%, 1.97% and 23.96%, respectively.

  • 6.Does Panacea Biotec Ltd pay dividends?

    No, Panacea Biotec Ltd does not pay dividends to eligible shareholders currently.

  • 7.What are the latest financial results of Panacea Biotec Ltd?

    For January,2024, Panacea Biotec Ltd reported revenue of ₹494.00 crore and a net profit of ₹-8.37 crore.

  • 8.What is the Stock symbol of Panacea Biotec Ltd?

    PANACEABIO is the stock symbol of Panacea Biotec Ltd.

  • 9.Who is the CEO of Panacea Biotec Ltd?

    The CEO of Panacea Biotec Ltd is Rajesh Jain.

Open Your Free Demat Account

Enter your phone number